alpha-methylornithine has been researched along with Neoplasms in 1 studies
alpha-methylornithine: inhibitor of ornithine decarboxylase; RN given refers to cpd without isomeric designation
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oredsson, SM | 1 |
| Marton, LJ | 1 |
1 other study available for alpha-methylornithine and Neoplasms
| Article | Year |
|---|---|
Potential uses of polyamine biosynthesis inhibitors in tumor therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; DNA Repair; Drug Therapy, Combination; Eflornithine; Hum | 1984 |